Trials / Completed
CompletedNCT06481488
A Study of E2086 in Healthy Adult Participants
A Randomized, Double-Blind, Placebo-Controlled, Combined Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Single Dose Study to Assess Food Effect of E2086 in Healthy Adult Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Eisai Inc. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The primary purpose of the study is to evaluate the safety and tolerability following multiple ascending doses of E2086 in healthy adult participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | E2086 | E2086 tablets. |
| DRUG | Placebo | E2086 matched placebo tablets. |
Timeline
- Start date
- 2024-06-25
- Primary completion
- 2024-12-13
- Completion
- 2024-12-13
- First posted
- 2024-07-01
- Last updated
- 2025-01-16
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06481488. Inclusion in this directory is not an endorsement.